1-159171824-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001127173.3(CADM3):c.59C>G(p.Ala20Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 31)
Consequence
CADM3
NM_001127173.3 missense
NM_001127173.3 missense
Scores
2
5
12
Clinical Significance
Conservation
PhyloP100: 1.25
Genes affected
CADM3 (HGNC:17601): (cell adhesion molecule 3) The protein encoded by this gene is a calcium-independent cell-cell adhesion protein that can form homodimers or heterodimers with other nectin proteins. The encoded protein has both homophilic and heterophilic cell-cell adhesion activity. This gene is reported to be a tumor suppressor gene. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2763515).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CADM3 | NM_001127173.3 | c.59C>G | p.Ala20Gly | missense_variant | 1/9 | ENST00000368125.9 | NP_001120645.1 | |
CADM3 | NM_021189.5 | c.59C>G | p.Ala20Gly | missense_variant | 1/10 | NP_067012.1 | ||
CADM3 | NM_001346510.2 | c.59C>G | p.Ala20Gly | missense_variant | 1/9 | NP_001333439.1 | ||
CADM3 | XM_024448760.2 | c.59C>G | p.Ala20Gly | missense_variant | 1/12 | XP_024304528.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CADM3 | ENST00000368125.9 | c.59C>G | p.Ala20Gly | missense_variant | 1/9 | 1 | NM_001127173.3 | ENSP00000357107.4 | ||
CADM3 | ENST00000368124.8 | c.59C>G | p.Ala20Gly | missense_variant | 1/10 | 1 | ENSP00000357106.4 | |||
CADM3 | ENST00000416746.1 | c.59C>G | p.Ala20Gly | missense_variant | 1/7 | 1 | ENSP00000387802.1 | |||
AIM2 | ENST00000695582.1 | n.33+15987G>C | intron_variant |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.59C>G (p.A20G) alteration is located in exon 1 (coding exon 1) of the CADM3 gene. This alteration results from a C to G substitution at nucleotide position 59, causing the alanine (A) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Pathogenic
D;T;T
Sift4G
Pathogenic
D;T;T
Polyphen
D;D;.
Vest4
MutPred
Loss of stability (P = 0.0919);Loss of stability (P = 0.0919);Loss of stability (P = 0.0919);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.